Compass Capital Management Inc. Decreases Position in Danaher Corp. (DHR)
Compass Capital Management Inc. lowered its stake in shares of Danaher Corp. (NYSE:DHR) by 0.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 214,245 shares of the company’s stock after selling 533 shares during the period. Danaher Corp. makes up approximately 4.1% of Compass Capital Management Inc.’s investment portfolio, making the stock its 6th largest position. Compass Capital Management Inc.’s holdings in Danaher Corp. were worth $21,639,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the stock. Ngam Advisors L.P. boosted its stake in shares of Danaher Corp. by 25.0% in the first quarter. Ngam Advisors L.P. now owns 156,838 shares of the company’s stock valued at $14,877,000 after buying an additional 31,331 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. boosted its stake in shares of Danaher Corp. by 1.7% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 154,798 shares of the company’s stock valued at $14,684,000 after buying an additional 2,586 shares in the last quarter. Dubuque Bank & Trust Co. boosted its stake in shares of Danaher Corp. by 26.8% in the first quarter. Dubuque Bank & Trust Co. now owns 35,533 shares of the company’s stock valued at $3,371,000 after buying an additional 7,501 shares in the last quarter. Addenda Capital Inc. boosted its stake in shares of Danaher Corp. by 0.3% in the first quarter. Addenda Capital Inc. now owns 69,110 shares of the company’s stock valued at $6,566,000 after buying an additional 208 shares in the last quarter. Finally, Torray LLC boosted its stake in shares of Danaher Corp. by 45.7% in the first quarter. Torray LLC now owns 803,894 shares of the company’s stock valued at $76,257,000 after buying an additional 252,050 shares in the last quarter. Institutional investors own 75.74% of the company’s stock.
Shares of Danaher Corp. (NYSE:DHR) traded down 0.42% during trading on Tuesday, reaching $77.66. The company had a trading volume of 1,984,522 shares. Danaher Corp. has a 1-year low of $61.60 and a 1-year high of $82.64. The company’s 50 day moving average is $79.06 and its 200-day moving average is $76.56. The stock has a market capitalization of $53.63 billion, a price-to-earnings ratio of 15.45 and a beta of 1.13.
Danaher Corp. (NYSE:DHR) last issued its quarterly earnings data on Monday, July 25th. The company reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.03. The company earned $5.80 billion during the quarter, compared to the consensus estimate of $5.76 billion. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. Danaher Corp.’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.08 earnings per share. On average, equities research analysts anticipate that Danaher Corp. will post $3.56 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Wednesday, September 28th. Danaher Corp.’s dividend payout ratio (DPR) is 9.94%.
DHR has been the subject of a number of recent analyst reports. Goldman Sachs Group Inc. initiated coverage on Danaher Corp. in a research report on Tuesday, July 5th. They set a “neutral” rating and a $74.00 price target for the company. Sanford C. Bernstein raised Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price target for the company in a research report on Thursday, June 23rd. JPMorgan Chase & Co. reaffirmed a “buy” rating and set a $105.00 price target on shares of Danaher Corp. in a research report on Thursday, June 30th. Citigroup Inc. increased their target price on Danaher Corp. from $102.00 to $104.00 and gave the stock a “neutral” rating in a research report on Monday, June 13th. Finally, Zacks Investment Research lowered Danaher Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, June 29th. Nine research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $93.98.
In other news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the company’s stock in a transaction on Monday, August 1st. The stock was sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the transaction, the insider now directly owns 179,054 shares of the company’s stock, valued at $14,582,157.76. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Daniel L. Comas sold 96,446 shares of the company’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total value of $7,800,552.48. Following the transaction, the chief financial officer now directly owns 215,716 shares in the company, valued at $17,447,110.08. The disclosure for this sale can be found here. 12.60% of the stock is currently owned by corporate insiders.
Danaher Corp. Company Profile
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Receive News & Stock Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related stocks with our FREE daily email newsletter.